seladelpar
FDA Approves Seladelpar for Primary Biliary Cholangitis
The FDA has granted accelerated approval to Livdelzi in combination with ursodeoxycholic acid for adults with PBC.
AUGUST 23, 2024
Seladelpar Improves Transplant-Free Survival at 2 Years
San Diego—If approved, a therapy in development for primary biliary cholangitis might allow some patients ...
OCTOBER 19, 2022
Load more